STOCK TITAN

Cenntro (CENN) SEC Filings

CENN NASDAQ

Cenntro Inc.'s SEC filings document the formal reporting record of a Nevada electric commercial vehicle company with common stock listed on Nasdaq under CENN. Recent 8-K disclosures cover Nasdaq minimum bid-price compliance, amendments tied to a reverse stock split, capital-stock changes and Regulation FD press-release exhibits.

The filings also record material financing terms, including a secured convertible promissory note exchange, and governance matters from annual meeting results, director elections and auditor ratification. Periodic-reporting notices such as Form NT 10-K address filing timing, while proxy statement disclosures describe shareholder voting matters and board authorization affecting the company’s capital structure.

Rhea-AI Summary

Cenntro Inc. amended its report solely to add a legal opinion from Wendot Law Group, its newly engaged Nevada counsel, and the related consent in connection with the company’s at-the-market offering. The amendment does not update other disclosures in the original report and is incorporated by reference into Cenntro’s Form S-3 registration statement, subject to documents or reports subsequently filed or furnished.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cenntro Inc. (CENN) entered into an at-the-market sales agreement allowing it to offer and sell up to $100,000,000 of common stock through Pacific Century Securities, LLC. Cenntro is not obligated to sell shares. After a placement notice is delivered, the sales agent will use commercially reasonable efforts to sell under Cenntro’s instructions, unless the notice is declined, suspended or terminated under the agreement. The agent earns a 3.5% commission on gross proceeds from each sale and may use permitted market methods, including sales on Nasdaq Capital Market, other existing trading markets or through a market maker. The shares are offered under a prospectus supplement dated October 9, 2026, filed October 13, 2026, to Cenntro’s Form S-3 registration statement, declared effective February 12, 2026. Cenntro agreed to reimburse up to $100,000 of reasonable out-of-pocket expenses for the initial offering; $50,000 was paid under a September 1, 2026 engagement letter, and up to $50,000 is payable upon closing of the first placement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cenntro Inc. (CENN) may offer and sell common stock with an aggregate offering price of up to $100,000,000 through an at-the-market agreement with Pacific Century Securities, LLC. Sales may occur from time to time; the agent will use commercially reasonable efforts but is not required to sell a specific amount. Cenntro will pay a 3.5% commission on gross proceeds from shares sold. The common stock closed at $3.90 per share on October 8, 2026, and 17,585,452 shares were outstanding as of October 9, 2026.

Cenntro says most operating revenue is generated outside the PRC, while a substantial portion of its consolidated assets is located there. Restrictions on distributing PRC subsidiaries’ net assets were approximately $26.8 million, or 79% of total consolidated net assets, as of June 30, 2026. Cenntro believes it is not currently required to file with the CSRC for this offering, while acknowledging substantial uncertainty in PRC rules and possible differing government interpretations that could affect operations or securities offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Cenntro Inc. (CENN) stockholders approved by written consent, following board approval, an increase in authorized common stock from 3,000,000,000 to 10,000,000,000 shares and an expanded reverse-split ratio range from 1-for-2 to 1-for-2,000. The consent covered 16,514,562 shares, a majority of the 17,585,452 shares outstanding on September 24, 2026.

The common-stock authorization amendment is expected to take effect on or about October 27, 2026. The board may choose the reverse-split ratio and effect the split any time before the one-year anniversary of approval. The company says the newly authorized shares are available for future issuance as determined by the board, while also stating it has no current plan or commitment to issue them; future issuances could dilute existing holders. The actions cannot be implemented until at least 20 days after the information statement is first sent or given to stockholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Cenntro Inc. received written-consent approval to increase its authorized common shares from 3,000,000,000 to 10,000,000,000. The amendment is to take effect on or about October 30, 2026. The company states it has no current plan, commitment, arrangement, understanding or agreement to issue the additional authorized shares, though future issuance could dilute existing ownership.

Stockholders also approved widening the authorized reverse stock split ratio range from 1-for-2 to 1-for-2,000. The Board will determine the exact ratio and may effect the split before the one-year anniversary of the September 24, 2026 approval. The written consent covered 16,514,562 shares, representing a majority of the 17,585,452 common shares outstanding as of September 24, 2026. Other stockholders are being informed and are not being asked to vote.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Cenntro Inc. (CENN) reported that it amended its existing securities purchase agreements with accredited investors to expand a previously announced private placement of common stock. The amendment increased the offering from up to 12,800,000 shares to up to 15,120,000 shares of common stock at a purchase price of $3.773 per share, for an aggregate amount of up to $57,047,760.

The private placement closed on September 15, 2026, and the company received aggregate gross proceeds of approximately $57,047,760. Cenntro states that it intends to use the proceeds for working capital and general corporate purposes. The shares were sold in a transaction relying on exemptions from registration under Section 4(a)(2) of the Securities Act and Regulation S, with each investor representing it is not a U.S. person and no general solicitation or public offering conducted.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Cenntro Inc. (CENN) entered into securities purchase agreements on August 25, 2026 for a private placement of up to 12,800,000 shares of common stock at $3.773 per share, based on the 5-day average Nasdaq official closing price, for expected gross proceeds of about $48.3 million. The company plans to use the proceeds for working capital and general corporate purposes.

The private placement is structured to comply with Nasdaq Listing Rule 5635(d), as the pricing is at or above the Nasdaq “Minimum Price,” allowing issuance without shareholder approval. The transaction relies on exemptions from registration under Section 4(a)(2) and Regulation S, with sales to non-U.S. persons and no general solicitation. Closing remains subject to customary conditions, and no shares have been issued yet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

Cenntro Inc. reported continuing net revenues of $7.4 million for the six months ended June 30, 2026, compared with $8.5 million in 2025, mainly from electric commercial vehicle and parts sales across Europe, Asia and America. Gross profit was $0.6 million. Operating expenses of $12.1 million, including a $2.9 million impairment on prepayments and other current assets and lower selling, G&A and R&D than a year earlier, led to a loss from operations of $11.5 million.

Other items included a $1.3 million gain from remeasurement of convertible notes and a $1.9 million loss on deconsolidation of Antric. Continuing operations posted a net loss of $11.7 million; discontinued European subsidiaries generated an additional $2.8 million loss, for a total net loss attributable to shareholders of $14.5 million and basic and diluted loss per share of $8.94. Cash used in operations was $5.5 million, partly offset by $5.0 million of net financing inflows and $3.9 million of stock proceeds held in a regulated collection account, leaving $4.3 million in cash and cash equivalents.

At June 30, 2026, Cenntro had $68.4 million in total assets, including $18.4 million of inventories and $15.1 million of property, plant and equipment, against $34.4 million of total liabilities, such as $4.8 million of bank borrowings, $2.6 million of convertible promissory notes and $5.7 million of contract liabilities. Total equity attributable to shareholders was $33.9 million. The company executed a 1‑for‑60 reverse stock split on April 13, 2026 and continued restructuring its European operations, with several subsidiaries and Antric deconsolidated and most European activities presented as discontinued operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

Cenntro Inc. implemented a Capital Stock Increase through a Certificate of Amendment effective July 20, 2026. Authorized common stock rose from 16,666,667 shares to 3,000,000,000 shares, and authorized preferred stock from 1,666,667 shares to 100,000,000 shares, each with $0.0001 par value.

The amendment was filed with the Nevada Secretary of State on July 22, 2026, following approval by stockholders holding a majority of the Company’s voting power via written consent dated June 12, 2026. No other changes were made to the Amended and Restated Certificate of Incorporation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Cenntro Inc. (CENN) notified stockholders that its board and majority holders approved corporate governance changes by written consent.

The actions include (1) increasing authorized Common Stock from 16,666,667 to 3,000,000,000 shares and Preferred Stock from 1,666,667 to 100,000,000, effective on or about July 20, 2026; (2) authorizing a reverse stock split at a ratio between 1-for-2 and 1-for-250, to be determined by the Board and effective within one year of approval; and (3) approving a Certificate of Change to update the Articles of Incorporation following the Reverse Stock Split.

The Written Consent was executed on June 12, 2026 by holders of 1,394,562 shares, a majority of the 2,465,452 shares issued and outstanding as of that date. The Information Statement was first furnished to stockholders on June 30, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy

FAQ

How many Cenntro (CENN) SEC filings are available on StockTitan?

StockTitan tracks 24 SEC filings for Cenntro (CENN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cenntro (CENN)?

The most recent SEC filing for Cenntro (CENN) was filed on October 21, 2026.